Regarding its application this impurity does not have a therapeutic use of its own. Instead it is used as a reference standard in pharmaceutical analysis. Laboratories utilize it to develop and validate analytical methods ensuring accurate detection and quantification of impurities in brinzolamide drug products.

The purpose of monitoring Brinzolamide Compound B impurity is to ensure the safety efficacy and quality of the final pharmaceutical product.

In terms of description Brinzolamide Compound B impurity is a structurally related chemical compound that differs slightly from the active pharmaceutical ingredient (API). Such impurities may arise due to side reactions incomplete reactions or chemical changes over time.